The efficacy and safety of pridopidine was assessed for the treatment of Huntington Disease (HD) in the phase 3 trial, PROOF-HD.
No takes yet. Share an insight, caveat, or question.
Geva et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: